Explore company profiles, quarterly results, announcements and ownership disclosures.
Loading the company view…
Shukra Pharmaceuticals Limited (NSE: SHUKRAPHAR), ISIN INE551C01044 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
SHUKRAPHAR last traded at ₹56.79 (-3.07%), with a 52-week range of ₹26.30 to ₹65.26 (as of 23 Sep 2026).
Shareholding as of Jun 2026: promoters 51.15%, FIIs 0.00%, DIIs 0.11%, mutual funds 0.00%.
EquiSense Score (ECS): 41/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.